date:Sep 14, 2012
y mechanisms.
The industry captains, led by Kiran Mazumdar-Shaw, chairman and managing director, Biocon, H Thomas Watkins, former president CEO, Human Genome Sciences, Inc, along with industry organisation heads, Alan Eisenberg, executive vice-president, Emerging Companies and Business Development, BIO, and P M Murali, president, ABLE, lay threadbare issues like strong intellectual property as well as patent enforcement, a strong tax and regulatory system, strong support for RD, streamlined sa